Страница 1 от 50 резултата
FIELD OF INVENTION
The present invention relates generally to the modification of electrical conduction properties within the body for therapeutic purposes. The device and methods are disclosed in the context of treating neurological and physiological disorders that affect a variety of anatomical
TECHNICAL FIELD
The present invention provides novel intermediates for preparing a phenoxyacetic acid derivative represented by general formula (X):
##STR00002## wherein R.sup.1 is a lower alkyl group, or a pharmaceutically acceptable salt thereof, which has .beta.3-adrenoceptor stimulating activity
TECHNICAL FIELD
The present invention provides novel intermediates for preparing a phenoxyacetic acid derivative represented by general formula (X):
##STR00002## wherein R.sup.1 is a lower alkyl group, or a pharmaceutically acceptable salt thereof, which has .beta.3-adrenoceptor stimulating activity
TECHNICAL FIELD
The present invention provides novel intermediates for preparing a phenoxyacetic acid derivative represented by general formula (X):
##STR00002## wherein R.sup.1 is a lower alkyl group, or a pharmaceutically acceptable salt thereof, which has .beta.3-adrenoceptor stimulating activity
TECHNICAL FIELD
The present invention provides novel intermediates for preparing a phenoxyacetic acid derivative represented by general formula (X):
##STR00002## wherein R.sup.1 is a lower alkyl group, or a pharmaceutically acceptable salt thereof, which has .beta.3-adrenoceptor stimulating activity
FIELD OF THE INVENTION
The present invention relates to salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines, to a process for producing them, to their use for producing pharmaceutical compositions and to pharmaceutical compositions containing these compounds.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines, to a process for producing them, to their use for producing pharmaceutical compositions and to pharmaceutical compositions containing these compounds.
BACKGROUND OF THE
TECHNICAL FIELD
This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity.
BACKGROUND OF THE INVENTION
The estrogen
TECHNICAL FIELD
This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity.
BACKGROUND OF THE INVENTION
The estrogen
TECHNICAL FIELD
This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity.
BACKGROUND OF THE INVENTION
The estrogen
TECHNICAL FIELD
This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity.
BACKGROUND OF THE INVENTION
The estrogen
TECHNICAL FIELD
This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity.
BACKGROUND OF THE INVENTION
The estrogen
TECHNICAL FIELD
This invention is generally directed to estrogen antagonists and agonists, and to compounds for inhibiting cytokines, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity, as well as to pharmaceutical compositions and methods
TECHNICAL FIELD
The present invention relates to novel phenylaminoalkyl-carboxylic acid derivatives and pharmaceutically acceptable salts thereof which are useful as medicaments.
BACKGROUND ART
It is known that three subtypes of sympathomimetic .beta.-adrenoceptors, which have been classified as
The present invention relates to an implantable pump for pumping hydraulic fluid to or from a hydraulically operable surgical implant inside a human's or an animal's body. The pump comprises a wall forming a chamber for the hydraulic fluid, the wall including a first wall portion and a second wall